{"id":"NCT00318812","sponsor":"Ottawa Hospital Research Institute","briefTitle":"Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure","officialTitle":"Heme Iron Polypeptide for the Treatment of Iron Deficiency Anemia in Pre-Dialysis Patients: A Pilot Randomized Controlled Study","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2007-05","primaryCompletion":"2011-12","completion":"2011-12","firstPosted":"2006-04-27","resultsPosted":"2014-05-02","lastUpdate":"2016-05-10"},"enrollment":55,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Anemia","Renal Failure"],"interventions":[{"type":"DRUG","name":"Heme Iron Polypeptide (Proferrin)","otherNames":["Proferrin"]},{"type":"DRUG","name":"Iron sucrose (Venofer)","otherNames":["Venofer"]}],"arms":[{"label":"Heme Iron","type":"EXPERIMENTAL"},{"label":"Venofer","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine if oral Heme Iron Polypeptide is as effective as intravenous (IV) iron sucrose in the treatment of iron-deficiency anemia for patients with chronic kidney disease.","primaryOutcome":{"measure":"Hemoglobin Concentration at 6 Months","timeFrame":"6 months","effectByArm":[{"arm":"Heme Iron","deltaMin":117,"sd":null},{"arm":"Iron Sucrose","deltaMin":113,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":["23514036"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":18},"commonTop":["constipation","abdominal cramps","Muscle cramps","Diarrhoea","Dyspepsia"]}}